InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Benathen Marc David, Chief Financial Officer. Insider active across 2 companies, notably LifeMD, Inc.. Aggregated, 8 filings have been published. Total volume traded: €89k. The latest transaction was disclosed on 27 January 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
025,000 shares0
Common Stock
SEC:0001362118-22-000005·
025,000 shares0
Common Stock
SEC:0001362118-22-000005:0·
€28,3617,831 shares@ €3.62160.017% mcap78.0% of flow
Common Stock, par value $0.01
SEC:0001362118-21-000049·
Ideal exit: 27 Aug 2022 (T+270)
€28,3617,831 shares@ €3.62160.017% mcap35.1% of flow
Common Stock, par value $0.01
SEC:0001362118-21-000049:0·
Ideal exit: 27 Aug 2022 (T+270)
€8,0131,297 shares@ €6.17770.0049% mcap22.0% of flow
Common Stock
SEC:0001362118-21-000029·
Ideal exit: 15 May 2022 (T+270)
€8,0131,297 shares@ €6.17770.0049% mcap9.9% of flow
Common Stock
SEC:0001362118-21-000029:0·
Ideal exit: 15 May 2022 (T+270)
€8,0651,099 shares@ €7.3388100.0% of flow
Common Stock
SEC:0001362118-21-000010·
Ideal exit: 13 Feb 2022 (T+270)
€8,0651,099 shares@ €7.33880.0049% mcap10.0% of flow
Common Stock
SEC:0001362118-21-000010:0·
Ideal exit: 13 Feb 2022 (T+270)
8 of 8 declarations
About Benathen Marc David
Marc David Benathen is the Chief Financial Officer of LifeMD, Inc. and LifeMD, Inc. He oversees all financial operations of the company, including financial planning, reporting, and compliance. In his role, Marc ensures that LifeMD maintains high standards of financial integrity and transparency. His experience in finance is crucial to support LifeMD's growth strategy.
